Patents by Inventor Shengjun Mao

Shengjun Mao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Application of ?-asarone in preparation of medicine for preventing or treating hemorrhagic stroke
    Patent number: 12636260
    Abstract: The present invention provides an application of ?-asarone in the preparation of a medicine for preventing or treating hemorrhagic strokes. ?-asarone has the structure shown in formula I, and may significantly improve short-term neurological deficits and long-term learning and memory functions of model rats, reduce cerebral edema, improve the permeability of the blood-brain barrier, and prevent or mitigate the atrophy of brain tissue during a recovery period. ?-asarone has a precise therapeutic effect on animal models of hemorrhagic stroke without obvious toxic side effects, and is expected to have great application prospects as a medicine for preventing/treating hemorrhagic strokes.
    Type: Grant
    Filed: July 22, 2021
    Date of Patent: May 26, 2026
    Assignee: CHENGDU XINRUI TAIKANG TECHNOLOGY CO., LTD.
    Inventors: Shengjun Mao, Xiaofeng Gao, Lijun Luo, Rui Li, Jian Zhang, Peng Yang, Di Zhang, Qi Liu, Huiyuan Yang
  • 1-(CYCLOBUTANEMETHYLIDENE)-2, 4, 5-TRIMETHOXYBENZENE COMPOUND AND PREPARATION METHOD AND USE THEREOF
    Publication number: 20250270159
    Abstract: A 1-(cyclobutylidenemethyl)-2,4,5-trimethoxybenzene compound and a preparation method and use thereof are provided, belonging to the field of drug development technology. The prepared 1-(cyclobutylidenemethyl)-2,4,5-trimethoxybenzene compound may be used for the preparation of an antiepileptic drug and drugs for treatment and/or prevention of traumatic craniocerebral injury disorders, ischemic stroke, hemorrhagic stroke, and Parkinson's disease.
    Type: Application
    Filed: April 16, 2025
    Publication date: August 28, 2025
    Applicant: CHENGDU XINRUI TAIKANG TECHNOLOGY CO., LTD.
    Inventors: Shengjun MAO, Rui LI, Jian ZHANG, Can LIAO, Ruijie YAN, Di ZHANG, Kai LI, Qi LIU
  • APPLICATION OF ALPHA-ASARONE IN PREPARATION OF MEDICINE FOR PREVENTING OR TREATING HEMORRHAGIC STROKE
    Publication number: 20230404945
    Abstract: The present invention provides an application of ?-asarone in the preparation of a medicine for preventing or treating hemorrhagic strokes. ?-asarone has the structure shown in formula I, and may significantly improve short-term neurological deficits and long-term learning and memory functions of model rats, reduce cerebral edema, improve the permeability of the blood-brain barrier, and prevent or mitigate the atrophy of brain tissue during a recovery period. ?-asarone has a precise therapeutic effect on animal models of hemorrhagic stroke without obvious toxic side effects, and is expected to have great application prospects as a medicine for preventing/treating hemorrhagic strokes.
    Type: Application
    Filed: July 22, 2021
    Publication date: December 21, 2023
    Inventors: Shengjun Mao, Xiaofeng Gao, Lijun Luo, Rui Li, Jian Zhang, Peng Yang, Di Zhang, Qi Liu, Huiyuan Yang